Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.72 is 44% above its 5-year average of -1.30, near the high end of its 5-year range (-1.54–-0.72).
31.10% above its 12-month average of -1.04.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.16.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.72
EARNINGS PER SHARE (EPS) AVG TTM
-1.04
EARNINGS PER SHARE (EPS) AVG 3Y
-1.27
EARNINGS PER SHARE (EPS) AVG 5Y
-1.30
EARNINGS PER SHARE (EPS) AVG 10Y
-3.18
EARNINGS PER SHARE (EPS) AVG 15Y
-1.59
EARNINGS PER SHARE (EPS) AVG 20Y
-3.52
CURRENT VS TTM AVG
+31.10%
CURRENT VS 3Y AVG
+43.53%
CURRENT VS 5Y AVG
+44.47%
CURRENT VS 10Y AVG
+77.33%
CURRENT VS 15Y AVG
+54.68%
CURRENT VS 20Y AVG
+79.56%
Alphatec Holdings, Inc.
Market Cap
$1.65B
Earnings Per Share (EPS)
-0.72
TTM Avg
-1.04
3Y Avg
-1.27
5Y Avg
-1.30
Market Cap
$1.65B
Earnings Per Share (EPS)
4.63
TTM Avg
1.23
3Y Avg
0.09
5Y Avg
-0.82
Market Cap
$1.71B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$1.57B
Earnings Per Share (EPS)
-0.44
TTM Avg
-0.04
3Y Avg
-0.09
5Y Avg
-0.12
Market Cap
$1.76B
Earnings Per Share (EPS)
0.19
TTM Avg
-0.34
3Y Avg
-0.57
5Y Avg
-0.59
Market Cap
$1.52B
Earnings Per Share (EPS)
0.38
TTM Avg
-0.16
3Y Avg
-0.18
5Y Avg
-0.35
Market Cap
$1.52B
Earnings Per Share (EPS)
-1.00
TTM Avg
-0.77
3Y Avg
-0.59
5Y Avg
-0.43
Market Cap
$1.78B
Earnings Per Share (EPS)
-3.36
TTM Avg
-4.53
3Y Avg
-5.16
5Y Avg
-4.47
Market Cap
$1.78B
Earnings Per Share (EPS)
N/A
TTM Avg
-3.33
3Y Avg
-3.33
5Y Avg
-3.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.65B | -0.72 | -1.04 | -1.27 | -1.30 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 4.63 | 1.23 | 0.09 | -0.82 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -2.74 | -3.74 | -3.13 | -1.84 |
| Certara, Inc. (CERT)vs › | $1.57B | -0.44 | -0.04 | -0.09 | -0.12 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 0.19 | -0.34 | -0.57 | -0.59 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.38 | -0.16 | -0.18 | -0.35 |
| GH Research PLC (GHRS)vs › | $1.52B | -1.00 | -0.77 | -0.59 | -0.43 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -3.36 | -4.53 | -5.16 | -4.47 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | N/A | -3.33 | -3.33 | -3.33 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
Trailing EPS (TTM)
$-0.72
Forward EPS (Est.)
$0.33
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.96 |
| 2024-12-31 | -1.13 |
| 2023-12-31 | -1.54 |
| 2022-12-31 | -1.47 |
| 2021-12-30 | -1.50 |
| 2020-12-31 | -1.18 |
| 2019-12-31 | -1.09 |
| 2018-12-31 | -0.82 |
| 2017-12-31 | -0.18 |
| 2016-12-31 | -3.53 |
| 2015-12-31 | -21.53 |
| 2014-12-31 | -1.59 |
| 2013-12-31 | -10.25 |
| 2012-12-31 | -2.06 |
| 2011-12-31 | -3.00 |
| 2010-12-31 | -2.19 |
| 2009-12-31 | -3.24 |
| 2008-12-31 | -7.59 |
| 2007-12-31 | -6.50 |
| 2006-12-31 | -11.37 |
| 2005-12-31 | -9.27 |
| 2004-12-31 | 0.72 |
| 2003-12-31 | -1.08 |
| 2002-12-31 | -1.33 |
| 2001-12-31 | 0.12 |
